Its principal application might be to tide over patients during periods of very low platelet counts or to provide transient increases in platelet numbers when invasive procedures are required.
especially in low- and middle-income nations. However, our knowledge of the detailed molecular processes involved in ICH remains insufficient, particularly those involved in the secondary injury stage ...
The RRVBC says several factors have contributed to the shortage including high usage of O-negative blood, low platelet collections last week and weather disruptions in the South causing delays in ...